• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《中国局部进展期胃癌标准淋巴结清扫范围专家共识(2022年版)》

[Chinese expert consensus on extent of standardized lymphadenectomy for locally advanced gastric cancer (2022 edition)].

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Apr 25;25(4):277-283. doi: 10.3760/cma.j.cn441530-20220322-00111.

DOI:10.3760/cma.j.cn441530-20220322-00111
PMID:35461192
Abstract

Currently, surgery-based comprehensive therapy plays an important role in the treatment of local advanced gastric cancer (LAGC), and standard lymph node dissection is a mainstay of gastric surgery. Radical gastrectomy with D2 lymph node dissection is widely accepted based on the international publications of randomized clinical trials, but the extent of lymph node dissection is controversial. An adequate lymph node dissection may improve prognosis and reduce complications, and D2+ lymphadenectomy may improve surgical outcomes in some selected patients. To improve the efficacy of LAGC therapies, the Gastric Cancer Association, China Anti Cancer Association took the lead and organized experts to discuss and vote, and finally formulated this expert consensus. It is hoped that this consensus can provide reference for clinicians and further improve the diagnosis and treatment level of LAGC in China.

摘要

目前,以外科手术为主的综合治疗在局部进展期胃癌(LAGC)的治疗中发挥着重要作用,标准淋巴结清扫是胃癌手术的主要手段。基于随机临床试验的国际出版物,D2淋巴结清扫的根治性胃切除术被广泛接受,但淋巴结清扫范围仍存在争议。充分的淋巴结清扫可能改善预后并减少并发症,对于某些特定患者,D2以上淋巴结切除术可能改善手术效果。为提高LAGC治疗的疗效,中国抗癌协会胃癌专业委员会牵头组织专家进行讨论和投票,最终制定了本专家共识。希望本共识能为临床医生提供参考,进一步提高我国LAGC的诊疗水平。

相似文献

1
[Chinese expert consensus on extent of standardized lymphadenectomy for locally advanced gastric cancer (2022 edition)].《中国局部进展期胃癌标准淋巴结清扫范围专家共识(2022年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Apr 25;25(4):277-283. doi: 10.3760/cma.j.cn441530-20220322-00111.
2
[Extent of lymphadenectomy for local advanced gastric cancer in the era of perioperative treatment and minimally invasive surgery].围手术期治疗与微创手术时代局部进展期胃癌的淋巴结清扫范围
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Apr 25;25(4):284-289. doi: 10.3760/cma.j.cn441530-20220322-00110.
3
Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.比较腹腔镜远端胃癌切除术(D2淋巴结清扫术加完整胃系膜切除术,D2+CME)与传统D2淋巴结清扫术治疗局部进展期胃腺癌的前瞻性随机对照试验:一项随机对照试验的研究方案
Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
4
[Chinese experts consensus on standardized surgical management of specimens from radical gastrectomy (2022 edition)].《中国专家关于胃癌根治术标本标准化外科处理的共识(2022年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Feb 25;25(2):93-103. doi: 10.3760/cma.j.cn441530-20211122-00471.
5
[Quality control of lymph node dissection for locally advanced gastric cancer].[局部进展期胃癌淋巴结清扫的质量控制]
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Feb 25;27(2):148-152. doi: 10.3760/cma.j.cn441530-20231211-00209.
6
Current status and future perspectives in gastric cancer management.胃癌治疗的现状与未来展望
Cancer Treat Rev. 2000 Aug;26(4):243-55. doi: 10.1053/ctrv.2000.0164.
7
[Current status and research progress of lymph node dissection in advanced upper gastric cancer].[进展期上段胃癌淋巴结清扫的现状与研究进展]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):236-240.
8
[Discussion on standardized implementation of laparoscopic radical lymphadenectomy for distal gastric cancer].[关于远端胃癌腹腔镜根治性淋巴结清扫术标准化实施的探讨]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Aug 25;20(8):857-861.
9
[Interpretation of Chinese expert consensus on prevention and treatment of complications related to digestive tract reconstruction after laparoscopic radical gastrectomy for gastric cancer (2022 edition)].《中国腹腔镜胃癌根治术后消化道重建相关并发症防治专家共识(2022年版)》解读
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Feb 25;26(2):121-125. doi: 10.3760/cma.j.cn441530-20221031-00442.
10
[Chinese expert consensus on celiac lymphadenectomy during open/minimally invasive esophagectomy (2023 edition)].《开放/微创食管癌切除术中腹腔淋巴结清扫中国专家共识(2023年版)》
Zhonghua Zhong Liu Za Zhi. 2023 Oct 23;45(10):871-878. doi: 10.3760/cma.j.cn112152-20230330-00136.

引用本文的文献

1
Feasibility and long-term survival of proximal gastrectomy after neoadjuvant therapy for locally advanced proximal gastric cancer: A propensity-score-matched analysis.新辅助治疗后局部进展期近端胃癌行近端胃切除术的可行性及长期生存:一项倾向评分匹配分析
Chin Med J (Engl). 2025 Aug 20;138(16):1984-1990. doi: 10.1097/CM9.0000000000003232. Epub 2024 Aug 2.
2
A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.局部晚期胃癌和胃食管结合部腺癌的全新辅助治疗的前瞻性 II 期临床试验。
Sci Rep. 2024 Mar 29;14(1):7522. doi: 10.1038/s41598-024-58177-6.